0001493152-26-012991
SEC filingDermata Therapeutics issued a press release on March 26, 2026, reporting financial results for the year ended December 31, 2025, announcing a strategic pivot to direct-to-consumer skincare products under the Tome brand, and planning launches of Foundational Treatment in mid-2026 and Clearing Treatment shortly after.